FIELD: medicine.
SUBSTANCE: transdermal therapeutic system (TTS) contains at least one pharmacological biologically active substance heated to temperature exceeding that of skin, thus increasing penetrating speed of biologically active substance, including at least one reverse layer impermeable to biologically active substances at least one layer containing biologically active substance, and removable protective layer. The layer containing biologically active substance mainly consists of polysiloxane with partially dissolved biologically active substance.
EFFECT: intensified system-invoked release of biologically active substance.
13 cl, 2 ex, 1 dwg
Authors
Dates
2009-03-10—Published
2004-02-03—Filed